Faculty Spotlight

Head shot of Catherine McManus smiling while standing outdoors.

Catherine Rogers-McManus

Dr. McManus earned the Academy of Nutrition & Dietetics’ 2020 Mary Abbott Hess Award for Recognition of an Innovative Food/Culinary Effort for the culinary medicine research intervention, Diabetes Inspired Culinary Education (DICE), she developed for youth with type 1 diabetes. The intervention, which aimed to improve glycemic control and disease management behaviors among youth with type 1 diabetes, was implemented at a local grocery store teaching kitchen with the help of graduate and undergraduate students from the CWRU Nutrition Department. Dr. McManus received the Diabetes Nutritional Science & Metabolism 2021 Abstract Award at the American Diabetes Association national conference and the Academy of Nutrition & Dietetics’ 2021 Marie & August LoPresti Sr. Endowment Fund Faculty Development Award for the DICE intervention and her work in culinary medicine. In addition, Dr. McManus recently earned the Academy of Nutrition & Dietetics’ Abbott Nutrition Award in Women’s Health for the new Women’s Wellness course (NTRN 320) she developed. Expanding on her expertise in women’s health, she earned the CWRU Flora Stone Mather Center Research & Professional Development grant for her research and work expanding women’s health education.

Image of headshot of Sichun Yang

Sichun Yang

Case Western Reserve researchers uncover novel drug targets by piecing together receptor structures

Sichun Yang, PhD, Associate Professor, received an Exceptional Project award from the Breast Cancer Alliance and an omnibus grant from the National Cancer Institute. The Breast Cancer Alliance is a private foundation that is committed to recognize creative, unique and innovative research for breast cancer. Together with recent support from the Case Comprehensive Cancer Center and the Clinical and Translational Science Collaborative (CTSC), these awards will accelerate the drug discovery for advanced ER-positive breast cancer by harnessing an unprecedented “burning the bridge” strategy for estrogen receptor to develop “first-in-class” inhibitors to fight against endocrine therapy resistance.

More related findings have been featured in The Daily and also profiled in the annual Science Highlights at the Argonne National Lab as well as highlights from National Comprehensive Cancer Network newsletter.